… in reducing heart failure Events after Myocardial Infarction) trial … that the treatment effects of
sacubitril/valsartan vs ramipril … routine use of sacubitril/valsartan over ramipril in patients with …

… on the use of sacubitril/valsartan for heart failure, Heart Fail. … /valsartan vs enalapril in
patients with heart failure and … sacubitrilvalsartan implementation in a cohort of patients from …

… Products for Human Use. Evidence is also mounting for its … application in treating post-myocardial
infarction, chronic renal disease, stroke, as well as preserved ejection fraction heart …

… regarding the routine use of ACEI/ARB in patients with normal left ventricular function in this
… the impacts of ACEI/ARB on outcomes of ACS patients without heart failure (HF) after PCI. …

… implantation at one year post-myocardial infarction.The current use of primary prevention ICD
… Sacubitril with valsartan (Entresto) was approved for use in New Zealand during the follow-…

… in chronic symptomatic HF patients with decreased LVEF and … MI patients with LVSD were
randomizedto either valsartan/ … the use of prescribed novel emerging therapies in patients …

… with post-ischemia-induced new-onset heart failure after PS matching (n = 156). (B) Kaplan–…
of the use of SGLT2 inhibitors in patients with postischemia-induced new-onset heart failure …

… benefit of Sacubitril-Valsartan in left and right ventricular remodeling in patients with HFrEF,
and … Valsartan is an ARB drug widely used in clinics. It can reduce blood pressure and fight …

… Lower starting dose of sacubitril-valsartan (24/26 mg) may be used in selected patients and
… sacubitirl-valsartan compared with ramipril in addition to standard post-myocardial infarction …

… However, its low spatial resolution and the use of ionising … death in patients with a post-myocardial
infarction with … of patients with HFrEF in treatment with sacubitril/valsartan [87]. …